A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

Analysis of Antibody Drug Conjugates Contract Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan ROCKVILLE, MD, UNITED STATES, June 18, ...

NextCure gains global rights to SIM0505 excluding greater China, where Simcere Zaiming will retain rights; Phase 1 clinical ...

In this video, Sonali M. Smith, MD, discusses several notable studies on new treatment combinations and other options for ...

Antibody drug conjugates, or ADCs, are still holding on to their spot as one of the hottest areas in cancer care—and AbbVie, ...

Amerigo Scientific offers PerKitsTM drug conjugation kits to simplify and optimize the conjugation of small-molecule drugs to biomolecules. NE ...

NextCure has ramped up its antibody-drug conjugate (ADC) pivot, penning a $745 million deal for the ex-China rights to ...

Erika Hamilton, MD, discusses the mechanism of action of emiltatug ledadotin, a B7-H4-directed Dolasynthen antibody-drug conjugate.

Sunrock Biopharma SL and Shanghai Escugen Biotechnology Co. Ltd. have joined forces in a strategic partnership to codevelop ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

Novel chemoimmunotherapy platform aims to transform outcomes in one of the world’s deadliest cancersNEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a biotechnology company advancing ...